5Lee F, Chung JE, Kurisawa M. An injectable hyaluronic acid- tyramine hydrogel system for protein delivery [J]. J ControlRel, 2009, 134 (1): 186 -193.
6Baert L, Klooster G, Dries W, etal, Development of a long acting injectable formula*ion with nanoparticles of rilpivirine (TMC278) for HIV treatment [J].Eur J Pharm Biopharm, 2009, 72 (4): 502-508.
7Mansoor S, Kuppermann BD, Kenney MC. Intraocular sus- tained-release delivery systems for triamcinolone acetonide [J].PharmRes, 2009, 26 (4): 770-784.
8Ito Y, Ochii Y, Fukushima K, et al. Three-layered micro- capsules as a long-term sustained release injection preparation [J]. Int J Pharm, 2010, 384 (1-2): 53-59.
9Jordan F, Naylor A, Kelly CA, et al. Sustained release hGH microsphere formulation produced by a novel supercriticaI fluid technology: in vivo studies [J].J Control Rel, 2010, 141 (1): 153-160.
10Shavi GV, Nayak UY, Reddy MS, et al. Sustained release optimized formulation of anastrozoleloaded chitosan micro- spheres: in vitro and in vivo evaluation [J]. J Mater Sci: Ma- terMed, 2011, 22 (4): 865-878.
